Lkit Therapeutics: Exploiting Synethtic Lethality to Target p53 Mutant Cancers Using First-In-Class Potent and Selective Small Molecule Inhibitors of Lipid Kinases PI5P4Kα/β.
Asyst Therapeutics: Transformative Therapies for Polycystic Kidney Disease
Athena Therapeutics
Overcoming PARP Inhibitor Resistance in Cancers
Sulabha Biopharmaceuticals
Combatting Obesity Through a Novel Mechanism
"Precision Inhibition of Class IIA Histone Deacetylases for Pulmonary Arterial Hypertension"
Apira: Advancing Small Molecule Inhibitors of N-Glycosylation
Petragen: Novel Therapeutics for Periodontal Disease
